Redefining CVD risk: Cardiovascular-kidney-metabolic (CKM) syndromeOctober 11, 2023DiabetesCAD & Atherosclerosis
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19September 14, 2023Heart FailureDiabetesCOVID-19 Updates
Screening finds high rates of CVD in diabetes, COPD patientsAugust 30, 2023CAD & AtherosclerosisPreventive CareDiabetes
Medicare announces 10 drugs targeted for price cuts in 2026August 30, 2023Business of MedicineDiabetesHeart FailureVenous ThromboembolismThrombosis
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD riskAugust 28, 2023CAD & AtherosclerosisDiabetes
American Geriatrics Society 2023 updated Beers Criteria highlightsAugust 18, 2023Venous ThromboembolismDiabetesArrhythmias & EP
